The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that are currently known to result in obesity. This screening study will not include any investigational drugs. You will be asked to provide a DNA sample and answer some questions about your medical history and hunger.
Study Type
OBSERVATIONAL
Enrollment
5,966
Identification of individuals with POMC, LepR or PCSK1 genetic mutations
Time frame: 1 Year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PC
Birmingham, Alabama, United States
Synexus Clinical Research US, Inc. - Phoenix Southeast
Chandler, Arizona, United States
Clinical Research Advantage Inc.
Mesa, Arizona, United States
Tucson Neuroscience Research - M3 Wake Research
Tucson, Arizona, United States
Unnamed facility
Encino, California, United States
PRI, LLC - Los Alamitos - M3 Wake Research
Los Alamitos, California, United States
Axis Clinical Trails
Los Angeles, California, United States
Axis Clinical Trials
Los Angeles, California, United States
PRI, LLC - Newport Beach - M3 Wake Research
Newport Beach, California, United States
Nemours Foundation Alfred Dupont Children's Hospital
Wilmington, Delaware, United States
...and 48 more locations